Seagen  logo
Seagen SGEN

Quarterly report 2023-Q3
added 11-01-2023

report update icon

Seagen Market Cap 2011-2026 | SGEN

As of April 07, 2026 Seagen has a market cap of $ 42.2 B


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Seagen

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
26.3 B 23.5 B 26.4 B 18.2 B 11.8 B 7.9 B 8.05 B 4.26 B 3.85 B 5.62 B 3.47 B 2.15 B

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
26.4 B 2.15 B 11.8 B

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
BioNTech SE BioNTech SE
BNTX
62.9 B $ 91.28 0.11 % $ 27.2 B germanyGermany
MorphoSys AG MorphoSys AG
MOR
315 M - 2.43 % $ 254 M germanyGermany
I-Mab I-Mab
IMAB
127 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
33.6 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
168 B - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
549 M - -13.47 % $ 169 M franceFrance
Midatech Pharma plc Midatech Pharma plc
MTP
79 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
28.9 M - -1.52 % $ 24.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
16.7 M - -24.86 % $ 820 K usaUSA
Advaxis Advaxis
ADXS
1.87 M - -9.65 % $ 45.9 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
76.4 M - - $ 86.2 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.83 B - - - russiaRussia
Aeterna Zentaris Aeterna Zentaris
AEZS
41.4 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
14.1 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
724 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
32.8 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
19.6 M - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
2.32 M - -45.71 % $ 1.2 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
3.25 B - - $ 3.67 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.53 B - - $ 867 M germanyGermany
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
8.08 B $ 3.54 -20.81 % $ 238 B britainBritain
Akouos Akouos
AKUS
172 M - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
114 M - - $ 28.6 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
71.4 M - 3.16 % $ 1.9 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
40.8 B $ 330.34 3.6 % $ 43.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
269 M - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
38.2 M - 10.36 % $ 9.8 M usaUSA
AlloVir AlloVir
ALVR
13.1 M - 4.14 % $ 49.1 M usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
66.3 M $ 0.79 1.22 % $ 27.9 M israelIsrael
Atreca Atreca
BCEL
49 M - -11.76 % $ 5.79 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
664 K - -11.43 % $ 502 K usaUSA
argenx SE argenx SE
ARGX
13.8 B $ 748.25 0.25 % $ 25 B niderlandNiderland
Завод ДИОД Завод ДИОД
DIOD
661 M - - - russiaRussia
Фармсинтез Фармсинтез
LIFE
2 B - - - russiaRussia
Applied Molecular Transport Applied Molecular Transport
AMTI
22.1 M - - $ 10.1 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
4.09 M $ 0.89 -4.33 % $ 4.85 M chinaChina
Applied Therapeutics Applied Therapeutics
APLT
541 M - - $ 8.42 M usaUSA
Aptinyx Aptinyx
APTX
9.48 M - -39.0 % $ 4.57 M usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
5.03 M - -13.85 % $ 16.1 M usaUSA
AbbVie AbbVie
ABBV
400 B $ 206.69 -1.01 % $ 366 B usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
467 M $ 4.09 -0.97 % $ 437 M usaUSA
Aravive Aravive
ARAV
60.4 M - -13.39 % $ 1.45 M usaUSA
Viela Bio, Inc. Viela Bio, Inc.
VIE
427 M - - $ 2.91 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
962 M $ 3.39 -3.69 % $ 1.01 B canadaCanada
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
217 M $ 8.22 2.37 % $ 225 M israelIsrael
Ardelyx Ardelyx
ARDX
1.62 B $ 5.97 0.51 % $ 1.44 B usaUSA
Genmab A/S Genmab A/S
GMAB
25 B $ 27.75 0.91 % $ 17.6 B danmarkDanmark
Cerevel Therapeutics Holdings Cerevel Therapeutics Holdings
CERE
6.68 B - - $ 7.29 B usaUSA
Grifols, S.A. Grifols, S.A.
GRFS
8.42 B $ 8.23 -0.12 % $ 6.83 B spainSpain
Akebia Therapeutics Akebia Therapeutics
AKBA
334 M $ 1.32 -4.35 % $ 339 M usaUSA